BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 03/31/2016

Position Statistics

Total Positions 82
New Positions 1
Increased Positions 11
Decreased Positions 40
Positions with Activity 51
Sold Out Positions 18
Total Mkt Value (in $ millions) 931

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 1.17%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 79.45%
Services
Technology
Transportation
Utilities

18 Sold Out Positions as of 03/31/2016

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held ▲
AMAG PHARMACEUTICALS INC COM -7,761 Sold Out 0
AMPHASTAR PHARMACEUTICALS INC COM -17,705 Sold Out 0
AMPLIPHI BIOSCIENCES CORP COM NEW -845 Sold Out 0
ATRICURE INC COM -12,302 Sold Out 0
BIODEL INC COM NEW -670 Sold Out 0
BIOLINERX LTD SPONSORED ADR -2,835 Sold Out 0
CARBYLAN THERAPEUTICS INC COM -711 Sold Out 0
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR -9,896 Sold Out 0
DEPOMED INC COM -13,786 Sold Out 0
EMERGENT BIOSOLUTIONS INC COM -21,762 Sold Out 0
FATE THERAPEUTICS INC COM -1,894 Sold Out 0
GENOCEA BIOSCIENCES INC COM -3,436 Sold Out 0
ORASURE TECHNOLOGIES INC COM -4,429 Sold Out 0
PALATIN TECHNOLOGIES INC COM PAR $ .01 -783 Sold Out 0
RIGEL PHARMACEUTICALS INC COM NEW -7,063 Sold Out 0
ST JUDE MED INC COM -16,340 Sold Out 0
TITAN PHARMACEUTICALS INC DEL COM NEW -3,814 Sold Out 0
VALEANT PHARMACEUTICALS INTL I COM -20,538 Sold Out 0


Latest News Headlines

View All Latest Headlines
Create your free portfolio